Seattle’s esteemed research institutions, including the University of Washington and Fred Hutchinson Cancer Center, are confronting significant challenges due to proposed federal budget cuts targeting the National Institutes of Health (NIH). These cuts threaten to disrupt critical biomedical research and patient care advancements in the region.
Proposed NIH Funding Reductions
The Trump administration’s 2026 budget proposal includes a $18 billion reduction to the NIH, representing a nearly 40% decrease in its budget. This reduction would eliminate four NIH institutes and consolidate others, significantly impacting ongoing research projects .
Impact on Seattle’s Research Communit
Seattle’s research community is particularly vulnerable to these cuts. In 2024, Washington state received approximately $1.4 billion in NIH and National Science Foundation funding, ranking ninth among U.S. states in funding per 1,000 residents. Institutions such as the University of Washington, Fred Hutchinson Cancer Center, and Seattle Children’s Hospital are major recipients of this funding .
Dr. Tom Grabowski, a neurologist at the University of Washington’s Memory and Brain Wellness Center, expressed concern that these cuts could set back medical research by decades. The NIH’s support is crucial for studies on Alzheimer’s disease and other neurological conditions .
Legal Challenges and Public Outcry
In response to the proposed cuts, legal actions have been initiated. A federal judge issued a temporary restraining order blocking the NIH’s policy to reduce indirect cost rates for research institutions, which would have further strained funding .
Additionally, public protests have erupted across the nation. On March 7, 2025, scientists and supporters gathered in Washington, D.C., and over 30 other U.S. cities, including Seattle, to demand increased funding for scientific research and oppose the administration’s policies .
Potential Consequences for Patients
The proposed funding reductions could have dire consequences for patients. Without adequate research funding, the development of new treatments and therapies may be delayed, affecting individuals relying on advancements in medical science.
Seattle’s research community continues to advocate for the restoration of NIH funding to ensure the continuation of vital medical research and the development of life-saving treatments.
